Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Harvard Business School
Julphar
Farmers Insurance
Johnson and Johnson
McKesson
McKinsey
Dow

Generated: December 16, 2018

DrugPatentWatch Database Preview

Acetaminophen; aspirin; caffeine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for acetaminophen; aspirin; caffeine and what is the scope of acetaminophen; aspirin; caffeine freedom to operate?

Acetaminophen; aspirin; caffeine is the generic ingredient in two branded drugs marketed by Perrigo and Glaxosmithkline Cons, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for acetaminophen; aspirin; caffeine. Thirty-one suppliers are listed for this compound.

Summary for acetaminophen; aspirin; caffeine
Synonyms for acetaminophen; aspirin; caffeine
52624-46-1
83535-74-4
Acetaminophen / aspirin / caffeine
Acetaminophen Mixture With Aspirin And Caffeine
Acetyl Salicylic Acid Paracetamol Caffeine
Anadin Extra
Anfengapilin
APC-AC
BENZOIC ACID,2-(ACETYLOXY)-,MIXT. WITH 3,7-DIHYDRO-1,3,7-TRIMETHYL-1H-PURINE-2,6- DIONE AND N-(4-HYDROXYPHENYL)ACETAMIDE
BKMBGNWZSQNIKU-UHFFFAOYSA-N
C9H8O4.C8H10N4O2.C8H9NO2
Cibalena A
Dikalm
EXCEDRIN (MIGRAINE)
Excedrin extra strength
LS-178504
NeoCitramonum
Neuranidal
OR349259
SCHEMBL4063268
Thomapyrin N

US Patents and Regulatory Information for acetaminophen; aspirin; caffeine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Cons EXCEDRIN (MIGRAINE) acetaminophen; aspirin; caffeine TABLET;ORAL 020802-001 Jan 14, 1998 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Perrigo ACETAMINOPHEN, ASPIRIN AND CAFFEINE acetaminophen; aspirin; caffeine TABLET;ORAL 075794-001 Nov 26, 2001 OTC No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for acetaminophen; aspirin; caffeine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Cons EXCEDRIN (MIGRAINE) acetaminophen; aspirin; caffeine TABLET;ORAL 020802-001 Jan 14, 1998 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Cons EXCEDRIN (MIGRAINE) acetaminophen; aspirin; caffeine TABLET;ORAL 020802-001 Jan 14, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Harvard Business School
Julphar
Farmers Insurance
Johnson and Johnson
McKesson
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.